Hosted on MSN2mon
Immedica to buy Marinus Pharmaceuticals for $151mGlobal rare disease company Immedica Pharma has agreed to acquire Marinus Pharmaceuticals for an enterprise value of approximately $151m. Marinus is a commercial-stage pharmaceutical company ...
STOCKHOLM, Sweden & RADNOR, PA – Immedica Pharma AB has announced its plan to acquire Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) in a transaction valued at approximately $151 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback